Antinuclear antibodies in schizophrenia and major depressive disorder - A lasting puzzle

European Psychiatry

Volumn 11, Issue 5, 1996, Pages 263-267

  Schott, K ^a   Uhl, A ^a   Batra, A ^a   Bartels, M ^a   Eusterschulte, B ^b   Buchkremer, G ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Fachklinik Rottenmünster   (Germany)

Author keywords

antinuclear antibodies; histones; major depressive disorder; schizophrenia

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOIA; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0029758795     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)82334-0     Document Type: Article

References (17)

1. Alarcon-Segovia D, Fischbein E, Cetina JA, Raya RJ, Barrera E. Antigenic specificity of chlorpromazine-induced antinuclear antibodies. Clin Exp Immunol 1973;15:543-8
2. Berglund S, Gottfries CG, Gottfries I, Stormby K. Chlorpromazine-induced antinuclear factors. Acta Med Scand 1970; 187:67-74
3. Brauchitsch H. Antinuclear factor in psychiatric disorders. Am J Psychiatry 1972;128:1552-4
4. Canoso RT, Oliveira RM, Nixon RA. Neuroleptic associated autoantibodies. A prevalence study. Biol Psychiatry 1990; 27:863-70
5. Chengappa KNR, Carpenter AB, Yang ZW, Brar JS, Rabin BS, Ganguli R. Elevated IgG antihistone antibodies in a subgroup of medicated schizophrenic patients. Schizophrenia Res 1992;7:49-54
6. Deberdt R, Van Hooren J, Biesbrouck M, Amery WA. Antinuclear factor - positive mental depression: a single disease entity? Biol Psychiatry 1976;11:69-74
7. Ganguli R, Rabin BS, Kelly RH, Lyte M, Ragu U. Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Ann NY Acad Sci 1987;496:676-85
8. Gompertz NR, Isenberg DA, Turner BM. Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes. Ann Rheum Dis 1990;49:524-7
9. Gottfries CG, Gottfries I. Antinuclear factors in relation to age, sex, mental disease and treatment with phenothiazines. Acta Psychiatr Scand 1974;255 (Suppl): 193-201
10. Johnston EC, Whaley K. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. Br Med J 1975;2:724-5
11. Legros S, Mendlewicz J, Wybran J. Immunoglobulins, auto-antibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatr Neurol Sci 1985;235: 9-11
12. Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Raus J. Antiphospholipid, antinuclear, Epstein-Bar and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. J Affective Dis 1991;21: 133-40
13. Sirota P, Firer MA, Schild K, Tanay A, Elizure A, Meytes D, Slor H. Autoantibodies to DNA in multicase families with schizophrenia. Biol Psychiatry 1993;33:450-5
14. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Arch Gen Psychiatry 1987;35:773-82
15. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151
16. Villemain F, Magnin M, Feuillet-Fieux MN, Zarifian E, Loo H, Bach JF. Antihistone antibodies in schizophrenia and affective disorders. Psychiatry Res 1988;24:53-60
17. Yannitsi SG, Manoussakis MN, Mauridis AK et al. Factors related to the presence of autoantibodies in patients with chronic mental disorders. Biol Psychiatry 1990;27:747-56